HOME >> MEDICINE >> NEWS
Chemotherapy for brain tumors is boosted after vaccine targets resistance-related antigen

LOS ANGELES (June 13, 2005) In the August issue of the journal Oncogene, researchers at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute describe a molecular mechanism that appears to make malignant brain tumors more vulnerable to chemotherapy after they have been treated with the dendritic cell vaccine.

This finding builds on several studies recently published by the research team. In 2003, they reported that a protein fragment previously found in melanomas also was detected in highly aggressive brain tumors called glioblastoma multiforme (GBM). The immune system recognizes the peptide, Tyrosinase-Related Protein (TRP)-2, as a foreign invader, making it a significant target for immunotherapy.

"Our findings suggest that TRP-2 could be a powerful molecule linking chemotherapy and immunotherapy," said Keith L. Black, M.D, one of the paper's authors, director of the Maxine Dunitz Neurosurgical Institute and director of the medical center's Division of Neurosurgery and Comprehensive Brain Tumor Program.

"Based on our results, it appears that we can improve chemotherapy sensitivity by targeting TRP-2 and possibly other drug-resistant related tumor antigens. This may be a significant step in the fight against brain tumors and other malignant cancers because even as we have been able to develop very powerful and targeted chemicals, tumors have often been able to outmaneuver them," said Black.

In 2004, the researchers documented that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of patients suffering from these deadly tumors. The two therapies together were able to accomplish results that neither could achieve by itself. The average length of survival was extended to about 26 months, compared to 18 months for patients who received vaccine alone and 16 months for those undergoing chemotherapy alone.

In a number of laboratory and clinical trials, den
'"/>

Contact: Sandy Van
sandy@prpacific.com
1-800-880-2397
Cedars-Sinai Medical Center
13-Jun-2005


Page: 1 2 3

Related medicine news :

1. Chemotherapy with bevacizumab increases risk of blood clots in arteries
2. Chemotherapy may enhance the effectiveness of brain tumor vaccines
3. Chemotherapy more effective when given before breast cancer surgery
4. Chemotherapy temporarily affects the structures of the human brain
5. Chemotherapy gel may fight breast cancer and reduce breast deformity
6. Chemotherapy given directly to the liver improves survival for patients with colorectal cancer
7. Chemotherapy after surgery extends survival for patients with advanced endometrial cancer
8. Chemotherapy errors rare, but have potential for serious consequences
9. Chemotherapy options improve for patients with advanced colorectal cancer
10. Draining away brains toxic protein to stop Alzheimers
11. New research discovers independent brain networks control human walking

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 07, 2020 , ... Midmark Corp., ... identified six trends that will significantly impact the point of care ecosystem, where ... shared between a provider and patient is the most important aspect of the ...
(Date:1/7/2020)... IRVINE, Calif. (PRWEB) , ... January 07, 2020 , ... ... CBD products can be created while keeping the focus on the individual customer service ... is putting their customers first and the profits second. By taking care of the ...
(Date:1/7/2020)... LAKE CITY and LAS VEGAS (PRWEB) , ... January 06, 2020 ... ... to announce its formation and unveil its first product: The LumaCare Duo ™. ... LumaCare booth (#44868) in the Sands Convention Center in Las Vegas, Nevada during CES ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... , which includes comprehensive presentations and procedures for hair restoration, facial rejuvenation and ... certificate available. , Regenerative aesthetics has become incredibly popular over the past few ...
(Date:1/5/2020)... ... January 04, 2020 , ... NJ Top Dentist, Dr. Irvin B. Sherman ... in treatment for infants, children, teens and the special needs patient. The practice is ... nursing and oral health. , Dr. Sherman and his practice will be addressing issues ...
Breaking Medicine News(10 mins):
(Date:1/3/2020)... TORONTO (PRWEB) , ... January 03, 2020 , ... Stay ... pharma, biotech, medical device and food industries. Access to all webinars is free, so ... stay relevant in your field. , Visit http://www.xtalks.com to see our upcoming ...
(Date:1/3/2020)... ... 03, 2020 , ... American actor, Laurence Fishburne, is well-known for his performances ... most know him for the movies he takes part in, he is also the ... explores a vast range of topics to educate its viewers about many issues taking ...
(Date:1/1/2020)... ... January 01, 2020 , ... Wireless Zone®, a Verizon ... the Children’s Tumor Foundation through its philanthropic Wireless Zone Foundation for Giving®. The ... in Orlando, Florida on October 7, 2019. The Children’s Tumor Foundation is one ...
Breaking Medicine Technology:
Cached News: